Home > Insider Trading > Filing (0001209191-15-028053)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1328143	Adamas Pharmaceuticals Inc	ADMS	Pharmaceutical Preparations (2834)	421560076

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503381	W. William Ericson	C/O Mohr Davidow Ventures 3000 Sand Hill Road, #3-290 Menlo Park CA 94025		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-17	4,523	$18.00	506,805	No	4	S	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF
Common Stock	Disposition	2015-03-18	7,200	$18.04	499,605	No	4	S	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF
No	4	S	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,772,686	Indirect	MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Common Stock	265,150	Indirect	MDV VII, L.P.
Common Stock	6,043	Indirect	MDV ENF VII (A), L.P.
Common Stock	3,146	Indirect	MDV ENF VII (B), L.P.
Common Stock	25,661	Indirect	MDV VII Leaders' Fund, L.P.

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by MDV IX on December 15, 2014.
William Ericson is a Managing Member of Ninth MDV Partners, L.L.C., the general partner of MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P. William Ericson may be deemed to share voting and dispositive power over the shares held by MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $18.00 and $18.0900 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Seventh MDV Partners, L.L.C. is the general partner of MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF(B), L.P. and has sole voting and investment power over the shares. William Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with Mohr Davidow Ventures.